LAP3 and gastric cancer: Ubenimex is a broad-spectrum LPA protein inhibitor which can restrain the LAP proteins in many species, such as Leishmania, human liver fluke, plasmodium and E. multilocularis, and inhibit the migration and invasion in gastric cancer by alleviating the activity of the CD13/NAB1/MAPK pathway (28).